Starkebaum G, Arend W P, Nardella F A, Gavin S E
J Lab Clin Med. 1980 Aug;96(2):238-51.
These studies were performed to determine the relative contribution of immune complexes or antibodies reactive with PMNs to the elevated levels of IgG PMN-binding activity seen with sera from some patients with Felty's syndrome. Twenty-one sera from 19 patients with Felty's syndrome were fractionated by gel filtration on Sephadex G-200. Fourteen of the sera had elevated levels of IgG PMN-binding activity as measured by a sensitive IgG-specific antiglobulin inhibition technique. Ten of the G-200 excluded pools and eight of the G-200 IgG pools had levels of IgG PMN-binding activity greater than 2 S.D. above the mean value for normals.Significant correlations were observed between the levels of IgG PMN-binding activity in the sera and the values for both the G-200 excluded pools (r = 0.51) and the IgG pools (r = 0.69). These data suggested that both soluble immune complexes and antibodies reactive with PMNs contributed to the elevated serum levels of IgG PMN-binding activity seen with sera from some patients with Felty's syndrome. Further evidence for the presence of PMN-binding immune complexes in the sera of patients with Felty's syndrome was the strong correlation between the values of serum IgG PMN-binding activity and the levels of immune complexes as detected by C1q binding (r = 0.71) or analytical ultracentrifugation (r = 0.60). Studies of G-200 excluded samples adsorbed with human IgG coupled to Sepharose 4-B indicated that immune complexes containing rheumatoid factors contributed only in part to the increased levels of IgG PMN-binding activity and of C1q-binding activity. Confirmation of the presence of antibodies reactive with neutrophils was the finding of significantly greater binding to PMN with F(ab')2 fragments of IgG from four sera of patients with Felty's syndrome compared to F(ab')2 from normal sera. Adsorption studies suggested that the PMN-reactive antibodies did not possess rheumatoid factor activity.
进行这些研究是为了确定免疫复合物或与中性粒细胞反应的抗体对某些费尔蒂综合征患者血清中升高的IgG与中性粒细胞结合活性水平的相对贡献。对19例费尔蒂综合征患者的21份血清进行了Sephadex G - 200凝胶过滤分级分离。通过灵敏的IgG特异性抗球蛋白抑制技术测定,其中14份血清的IgG与中性粒细胞结合活性水平升高。G - 200排阻级分中的10份和G - 200 IgG级分中的8份,其IgG与中性粒细胞结合活性水平高于正常均值2个标准差。血清中IgG与中性粒细胞结合活性水平与G - 200排阻级分(r = 0.51)和IgG级分(r = 0.69)的值之间均观察到显著相关性。这些数据表明,可溶性免疫复合物和与中性粒细胞反应的抗体均导致了某些费尔蒂综合征患者血清中IgG与中性粒细胞结合活性水平的升高。费尔蒂综合征患者血清中存在与中性粒细胞结合的免疫复合物的进一步证据是,血清IgG与中性粒细胞结合活性值与通过C1q结合(r = 0.71)或分析超速离心法(r = 0.60)检测到的免疫复合物水平之间存在强相关性。对用偶联至琼脂糖4 - B的人IgG吸附的G - 200排阻样品的研究表明,含有类风湿因子的免疫复合物仅部分导致了IgG与中性粒细胞结合活性和C1q结合活性水平的升高。与正常血清的F(ab')2片段相比,费尔蒂综合征患者的4份血清的IgG的F(ab')2片段与中性粒细胞的结合显著增加,这证实了存在与中性粒细胞反应的抗体。吸附研究表明,与中性粒细胞反应的抗体不具有类风湿因子活性。